Calla Lily Clinical Care is a British medical device startup developing a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. We are initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Progesterone prescriptions have significantly increased following the Nov 2021 update to internationally-renowned NICE's guidance on miscarriages. Subsequent applications include treatments focused on menopause and on the vaginal microbiome. Our patented technology has received FDA clearance and was named one of TIME magazine’s Best Inventions of the Year.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2021